PlainRecalls
FDA Drug Moderate Class II Terminated

Teva Ethambutol Hydrochloride Tablets, USP, 400 mg, 100- count bottle, Rx Only,Distributed by Teva Pharmaceuticals, USA, Sellersville, PA., NDC 0555-0923-02.

Reported: March 12, 2014 Initiated: January 24, 2014 #D-1092-2014

Product Description

Teva Ethambutol Hydrochloride Tablets, USP, 400 mg, 100- count bottle, Rx Only,Distributed by Teva Pharmaceuticals, USA, Sellersville, PA., NDC 0555-0923-02.

Reason for Recall

CGMP Deviations: Ethambutol Hydrochloride Tablets, USP, 400 mg were manufactured using unapproved material: the incorrect gelatin excipient than specified in the product formulation.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
10405 tablets
Distribution
Nationwide.
Location
Horsham, PA

Frequently Asked Questions

What product was recalled?
Teva Ethambutol Hydrochloride Tablets, USP, 400 mg, 100- count bottle, Rx Only,Distributed by Teva Pharmaceuticals, USA, Sellersville, PA., NDC 0555-0923-02.. Recalled by Teva Pharmaceuticals USA. Units affected: 10405 tablets.
Why was this product recalled?
CGMP Deviations: Ethambutol Hydrochloride Tablets, USP, 400 mg were manufactured using unapproved material: the incorrect gelatin excipient than specified in the product formulation.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 12, 2014. Severity: Moderate. Recall number: D-1092-2014.